Trending

Feed

News

Sentiment

Earnings

Fundamentals

Info

home SymbolCLSD

Exchange: NASDAQ·Updated 10:37 AM EDT

CLSD Clearside Biomedical Inc

$0.249

$0.0013

(0.52%)

Today

Reported EarningsAug 18

Mkt Cap$1.3M

Vol3.00

About CLSD

Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases. Its pipeline includes CLS-AX, an Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.

Fundamentals

Mkt Cap

$1.3M

52W High

$13.05

52W Low

$0.01

PE Ratio

-0.05

Avg. Volume

4,235.19

Earnings

Aug 18

50

Neutral Sentiment

How do you feel about CLSD?

Connect Stocktwits to ChatGPT

New

Real-time sentiment, trending & news in ChatGPT

Sentiment
Watchers
Trending
News

Advertisement|Remove ads.

Latest CLSD News

CLSD Stock Plummets After Company Files For Bankruptcy Protection

Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Lags Revenue Estimates

Mersana Therapeutics, Inc. (MRSN) Reports Q3 Loss, Lags Revenue Estimates

Top Discussions

Nvidia ($NVDA) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

What do you expect from Nvidia ($NVDA) earnings on Wednesday?

Bitcoin just broke past $76,000 for the first time since late May. Where do you see it going from here?

Advertisement|Remove ads.

Advertisement|Remove ads.